Literature DB >> 8387788

Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance.

T Yoshikawa1, Y Naito, T Tanigawa, M Kondo.   

Abstract

The anti-free radical action of rebamipide (2-(4-chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl] propionic acid, CAS 11911-87-6), a novel anti-ulcer agent, was investigated by electron spin resonance spectroscopy. A spin trapping method using 5,5-dimethyl-1-pyrroline-N-oxide showed that rebamipide dose-dependently decreased both the intensity of the hydroxyl radical spin adduct signal generated by the Fenton reaction and the intensity of the superoxide spin adduct generated from opsonized zymosan-stimulated neutrophils. A kinetic study showed that the second order rate constant for the reaction between rebamipide and hydroxyl radicals at pH 7.8 was 2.24 x 10(10) mol l-1 s-1. These results indicate in vitro antioxidant properties of rebamipide which is active as hydroxyl radical scavenger and inhibitor of superoxide production in neutrophils.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387788

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  40 in total

1.  Local gastric and serum concentrations of rebamipide following oral ingestion in healthy volunteers.

Authors:  Taiji Akamatsu; Naoshi Nakamura; Naoyuki Furuya; Toshiki Shimizu; Akira Gotou; Kendo Kiyosawa; Tsutomu Katsuyama; Takahiko Osumi; Yukihiro Hirao; Gohatiro Miyamoto
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

2.  A study on the efficacy of rebamipide for patients with proton pump inhibitor-refractory non-erosive reflux disease.

Authors:  Kyoichi Adachi; Kenji Furuta; Hiroto Miwa; Tadayuki Oshima; Masaharu Miki; Yoshinori Komazawa; Katsuhiko Iwakiri; Takahisa Furuta; Tomoyuki Koike; Tomohiko Shimatani; Yoshikazu Kinoshita
Journal:  Dig Dis Sci       Date:  2012-02-26       Impact factor: 3.199

3.  Rebamipide protects against activation of neutrophils by Helicobacter pylori.

Authors:  N Yoshida; T Yoshikawa; S Iinuma; M Arai; S Takenaka; K Sakamoto; T Miyajima; Y Nakamura; N Yagi; Y Naito; F Mukai; M Kondo
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

4.  A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury taking aspirin with or without clopidogrel.

Authors:  Katsuyuki Tozawa; Tadayuki Oshima; Takuya Okugawa; Tomohiro Ogawa; Yoshio Ohda; Toshihiko Tomita; Nobuyuki Hida; Hirokazu Fukui; Kazutoshi Hori; Jiro Watari; Shiro Nakamura; Hiroto Miwa
Journal:  Dig Dis Sci       Date:  2014-08       Impact factor: 3.199

5.  Population pharmacokinetic analysis of rebamipide in healthy Korean subjects with the characterization of atypical complex absorption kinetics.

Authors:  Lien Ngo; Hee-Doo Yoo; Phuong Tran; Hea-Young Cho; Yong-Bok Lee
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-03-18       Impact factor: 2.745

6.  Rebamipide enemas-new effective treatment for patients with corticosteroid dependent or resistant ulcerative colitis.

Authors:  Mitsuki Miyata; Kunio Kasugai; Tetsuya Ishikawa; Shinichi Kakumu; Masafumi Onishi; Takeshi Mori
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

Review 7.  15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications.

Authors:  Tetsuo Arakawa; Kazuhide Higuchi; Yasuhiro Fujiwara; Toshio Watanabe; Kazunari Tominaga; Eiji Sasaki; Nobuhide Oshitani; Toshikazu Yoshikawa; Andrzej S Tarnawski
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

8.  An open-labeled study of rebamipide treatment in chronic gastritis patients with dyspeptic symptoms refractory to proton pump inhibitors.

Authors:  Taned Chitapanarux; Ong-ard Praisontarangkul; Nirush Lertprasertsuke
Journal:  Dig Dis Sci       Date:  2008-05-02       Impact factor: 3.199

Review 9.  Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: a systematic review and meta-analysis.

Authors:  Shaoheng Zhang; Qing Qing; Yang Bai; Hua Mao; Wei Zhu; Qikui Chen; Yali Zhang; Ye Chen
Journal:  Dig Dis Sci       Date:  2013-02-28       Impact factor: 3.199

10.  Small bowel tissue concentration of rebamipide: study of two dosages in healthy subjects.

Authors:  Taiji Akamatsu; Tadanobu Nagaya; Shinya Ichikawa; Takamori Sudo; Ryutaro Takeda; Kazuhiro Takenaka; Ryo Kodama; Tetsuya Ito; Norikazu Arakura; Eiji Tanaka
Journal:  J Clin Biochem Nutr       Date:  2010-10-29       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.